Skip to main content
Life Sci AI: The Podcast

Life Sci AI: The Podcast

By SciPro
A series of interviews with some of the industry's top professionals, discussing the latest topics circulating the world of science; brought to you by SciPro, Life Science Recruitment Specialists, and hosted by our very own expert consultant, Nick Mahoney.
Where to listen
Google Podcasts Logo

Google Podcasts

Pocket Casts Logo

Pocket Casts

RadioPublic Logo


Spotify Logo


Ep 5 | How AI Revolutionize the Pharma Industry
In this episode, Nick and Dr Bouarfa discuss her journey to becoming a CEO, the uniqueness of and most interestingly the future of female leaders in a STEM subject, particularly within Life Sciences. Dr Loubna Bouarfa is the founder and CEO of - a leading artificial intelligence (AI) company for life sciences, that supports the industry in bringing the right drug to the right patient at speed. Prior to, Loubna led different machine learning positions in startups and academia. Loubna was a member of the European Union High-Level Expert Group on Artificial Intelligence, where she mainly focused on achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO of the Year 2019 at the Cambridge Independent Science and Technology Awards and Best Female-Led Startup at the StartUp Europe Awards in 2019. Recently, Loubna has been selected as a European Young Leader (EYL40) for 2022. To speak to Nick, please drop an email to
August 16, 2022
Ep 4 | Using AI to improve Digestive Healthcare
In this awesome episode, Nick discusses with Alex Menys, CEO of Motilent, their current growth and more broadly the state of AI in MedTech. Alex Menys is the CEO of Motilent and his main focus is around measuring treatment response in Crohn's Disease but he is also actively involved in a range of projects around all things gastro including constipation, gastroparesis, IBS and any disease that features some form of GI symptom. Motilent specialises in the assessment of digestive diseases using medical image analysis. Their primary focus areas include Crohn’s Disease, Irritable Bowel Syndrome (IBS) and Gastroparesis although they support a range of projects across Digestive Health. This is a really intriguing episode because the clinical pathway of Motilent is so complex, and therefore Alex is a huge advocate and very vocal voice for the change needed within the Digestive Health pathway.
August 02, 2022
Ep 3 | AI for radiologists with Gleamer
In this episode, Nick talks to Albane Grandjean from Gleamer. Gleamer develops medical-grade AI solutions to support radiologists and emergency physicians in their daily work. Their solutions rely on powerful Artificial Intelligence algorithms, to detect and localise lesions on medical images. They have had great success in recent years with their first product, BoneView and they are now working on releasing additional products for utilisation by radiologists. Albane Grandjean is Head of Marketing & Clinical Affairs & General Manager. With more than 10 years of experience in marketing & commercial roles in Healthcare, Albane brings her passion for innovation in care and knowledge of medical imaging devices. What is particularly interesting about this episode is how Gleamer has underpinned their development within clinical experts for every product and Albane highlights this as a key to their successes. To speak to Nick, please drop an email to
July 19, 2022
Ep 2 | Building a Remote Patient Monitoring Platform
For the second episode of series 3, Nick discussed with Sebastian Durandeu from Feebris the transition into MedTech, what to expect when it comes to documentation, and working with ML on the edge.  Sebastian is the Head of Software Engineering at Feebris where he leads the software team building the next generation of remote patient monitoring tools using machine learning. He is a software engineer with 10+ years of experience and in the past he has helped numerous companies build applications and services for the Cloud and adopt emerging technologies. For those who are thinking about making the leap to MedTech, this is a really interesting episode to listen to. To speak to Nick, please drop an email to
July 05, 2022
Ep 1 | Using AI in Drug Discovery for Rare Diseases
We are back for series 3 of Life Sci AI: The Podcast. In the first series, we were honoured to be joined by Dr Tim Guilliams, the CEO and Co-Founder of Healx. Healx have created a suite of AI products and platforms to revolutionise the drug discovery process of rare diseases. It is a truly exciting time for Healx as their first process has reached clinical trials! Tim is a tech entrepreneur from the Cambridge Cluster, passionate about using AI to accelerate treatments for rare diseases. The mission-driven technology company, Healx are pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. In this role, Tim has been listed in The Sunday Times Maserati 100 list of entrepreneurs in 2019, was named as ‘One to watch’ in The Telegraph’s Top 50 Most Ambitious Business Leaders in 2020, and was selected as a member of the Forbes Technology Council in 2022. Tim is also the Co-Founder and Trustee of the Cambridge Rare Disease Network (CRDN). Prior to Healx and CRDN, he obtained his PhD at the University of Cambridge in the field of Biophysics and Neuroscience, developing nanobody technology for Parkinson's disease. Before moving to Cambridge, UK, Tim obtained an MEng in Bio- and Chemical-Engineering from the University of Brussels. To speak to Nick, please drop an email to
June 20, 2022
Ep 7 | Building an AI platform to tackle complex diseases
In the final episode of series 2, Nick is joined by Dr.Muhunthan Thillai, the co-founder and CEO of Qureight and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company.  Dr.Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension. To speak to Nick, please drop an email to
February 01, 2022
Ep 6 | Breast Cancer Diagnostics using AI
In this episode, Nick Mahoney speaks with Dr Mickael Tardy, the CSO from Hera-Mi. This episode is not one to be missed if you are looking to learn about taking risks and the opportunities available in Europe for international learning in software development and especially in medical imaging. Mickael Tardy is a CSO of Hera-MI, a medical imaging software company in Nantes (France), building AI-based solutions for healthcare, focusing primarily on breast cancer.  Mickael studied in Russia and France for his double degree in engineering before starting as a software engineer in medical imaging. After seven years in the field and looking for a new challenge, Mickael joined Hera-MI in its early days and started a PhD in Deep Learning while building the company at the same time. Today, after defending his PhD, Mickael takes care of all the research activities at Hera-MI, aiming for production-ready solutions. To speak to Nick, please drop an email to
January 17, 2022
Ep 5 | Charco: CUE1 for Parkinson's
In this episode, Nick speaks with Lucy Jung, Co-Founder of Charco Neurotech. Charco has created an incredible device that reduces the symptoms of Parkinson’s for patients and helps them live as close to normal lives as possible. Lucy’s passion for bettering the lives of those with Parkison’s is truly infectious, and hopefully, you will all be inspired by this episode. Lucy Jung co-founded Charco Neurotech after meeting members of the Parkinson's community whose symptoms prevented them from smiling. From then it has been Charco's goal to bring back smiles for people with long-term conditions. With a background in product design, Lucy conceived the CUE1 while studying the Innovation Design Engineering Master's at Imperial College and the Royal College of Art. With the support of some incredible institutions, advisors, and people with Parkinson's, this went on to become Charco Neurotech. To speak to Nick, please drop an email to
December 14, 2021
Ep 4 | Medical Image Analysis in the Lungs
In this great episode, Nick speaks with Eva van Rikxoot, CEO of Thirona, and found out about not only the amazing work they do in medical image analysis but also the fantastic approach to hiring they have had from their foundation. This has led them to be a microcosm of the global community for which they serve! Eva van Rikxoort is the founder and CEO of Thirona, an internationally fast-growing company in Nijmegen (The Netherlands), specializing in the field of AI-powered medical image analysis.  Eva obtained her Ph.D. on Segmentation of Anatomical Structures in Chest CT Scans from the University Medical Center Utrecht, followed by a two-year postdoc position in quantitative image analysis at the University of California-Los Angeles.   Since its inception in 2014, Thirona has established itself as a highly innovative partner for early drug and treatment development through clinical implementation, ultimately aiming at supporting clinical specialists in accurate diagnosis and personalized patient care. To speak to Nick, please drop an email to
November 26, 2021
Ep 3 | Building Neural Digital Therapeutics
In this episode, Nick discusses the incredibly cutting edge world of neural interfaces and the work BIOS is doing to create Neural Digital Therapeutics to help in the treatment of cardiovascular diseases. This incredible episode shows what it takes to be a the forefront of AI research within Life Sciences... This is one not to be missed. Oliver was driven from an early age by a vision that technology could and should repair and support the human body. Oliver studied for his PhD on tissue and materials integration at the Nanoscience Centre, University of Cambridge. He wanted to understand how a device could be implanted inside the human body without harming it. He later moved to Canada to continue his research at McGill University, before founding BIOS in 2015 alongside co-founder Emil Hewage. The two shared a bold vision for reading and writing the nervous system. Oliver was named in Forbes’ 30 Under 30 in 2018. To speak to Nick, please drop an email to
November 15, 2021
Ep 2 | AI for Molecular Imaging for Drug Discovery
In this special episode, Nick speaks with both Mark Lynch and Andrii Kulakovskyi to discuss the new BioIT department at Genomic Vision and how they are using AI and Image Processing to aid drug discovery! Andrii established the BioIT department (branch of R&D organisation) working on the development of tools for automated fluorescence image processing and analysis in order to deliver new products to help their customers in different sectors of the healthcare market in which Genomic Vision technology is being utilized. Mark joined Genomic Vision in March 2021 to define the product strategy and market segments to drive new growth in the company's molecular combing technology and to contribute to Genomic Vision’s strategy to develop and commercialise new applications by molecular combing. To speak to Nick, please drop an email to
November 02, 2021
Ep 1 | Surgical Robotics
In this first episode to kick off series 2, Nick speaks with Dr Lucien Blondel all about his journey and passion for surgical robotic development! Dr Lucien Blondel is the CTO and Co-founder of Quantum Surgical SAS, an innovative medical robotics company commercializing the Epione® robot intended to assist physicians during percutaneous ablations in the abdomen. Lucien BLONDEL has 20+ years of experience in medical robotics and medical imaging in both startup and corporate environments. To speak to Nick, please drop an email to
October 19, 2021
Ep 9 | Reaching FDA Approval
In episode 9, Nick Mahoney, has an in-depth discussion with Dr Vaclav Potesil, Founder of Optellum. Optellum have recently achieved FDA approval and the world’s first AI-powered Clinical Decision Support Software for Early Lung Cancer Diagnosis. What stands out in this episode is the incredible inception story of Optellum and when/where Dr @Vaclav Potesil chose that the time was right to start this incredible journey. To speak to Nick, please drop an email to
May 14, 2021
Ep 8 | Combining Cloud Architecture and Deep Learning to Revolutionize Stroke Diagnosis
In episode 8, Nick Mahoney, has an in-depth discussion with Renan Sales Barros, CTO of NICO.LAB. NICO.LAB are revolutionary company based in Amsterdam who have recently secured €13m in Series A funding. They have created a cloud-based AI driven stroke diagnostic tool, which is being utilised across the Netherlands. In this episode Nick speaks to Renan about his incredible journey… considering his first ever job was their CTO! To speak to Nick, please drop an email to
April 30, 2021
Ep 7 | Creating a Business Case for the Use of AI in Hospitals
In episode 7, Nick Mahoney, has an in-depth discussion with Jeroen van Duffelen, CBO of Aidence Jeroen van Duffelen is the CBO of Aidence – a start-up based in Amsterdam who is seeking to harness Deep Learning for Lung Cancer diagnostics through their product: Veye Lung Nodules To speak to Nick, please drop an email to
April 16, 2021
Ep 6 | The Importance of a Software Platform for the Widescale Use of AI in Healthcare
In episode 6, Nick Mahoney, discusses the incredible work of Blackford with CEO & Founder, Ben Panter.  The company’s Blackford Platform streamlines the procurement, deployment, use and support of a curated marketplace of clinical application and AI products. The Blackford Curated Marketplace contains over 40 clinical applications, all regulatory cleared and validated in clinical environments. The Blackford Platform manages interactions with the entire radiology clinical workflow through a single integration point. The company’s products are in use in over 700 hospitals, radiology groups and imaging centres worldwide. To speak to Nick, please drop an email to
April 01, 2021
Ep 5 | Deep Learning for MRI Scanning
In episode 5, Nick Mahoney, discusses the incredible work of Cerebriu with Dr Akshay Pai. Cerebriu is using Deep Learning to automate decision making MRI scans to enable an increase in data efficiency giving to Radiologists. Dr Akshay Pai, PhD, originally from India, currently based in Copenhagen, and a Co-founder & CTO at Cerebriu has more than a decade of experience in machine learning in medical imaging and key inventor across several patents. To speak to Nick, please drop an email to
March 21, 2021
Ep 4 | Neuromodulation, an introduction and its future
In this episode, Dr Jonathan O’Keefe, CEO of Machine Medicine joins Nick to discuss Machine Medicine’s innovative medical device in neuromodulation. In the episode, Dr O’Keefe outlines his transition from the NHS to startup CEO and along with Nick, they tackle the ethical limits of Neuromodulation. Dr O’Keeffe first studied philosophy where he became interested in the interface between artificial and natural intelligence. Subsequently, he trained as a medical doctor and practised for several years while undertaking an MSc in machine learning at UCL and completing a PhD in computational neuroscience at Cambridge. He then retired from clinical practice to start Machine Medicine, a company utilising computer vision to measure physical impairment or disability. Machine Medicine currently focuses on Parkinson’s disease and is being deployed in numerous clinical trials, both commercial and non-commercial. To speak to Nick, please drop an email to
March 04, 2021
Ep 3 | AI for Advanced Surgical Guidance
In this episode Dr Rob Hague joins Nick, to discuss the growth of Cydar in developing a product that utilizes computer vision and cloud computing for surgical guidance. Key in this episode is Rob’s explanation of rendering and visualization techniques they use and the challenges they first faced when they had to use standards from 1997. Rob Hague is the CTO of Cydar Medical, a UK startup using computer vision and cloud computing to provide advanced surgical guidance. He’s worked in both research and product development, ranging from user interfaces and ubiquitous computing to low- level application infrastructure and algorithm implementation. To speak to Nick, please drop an email to
February 19, 2021
Ep 2 | Product Development for Medical Imaging Devices
We were really lucky to be joined by Dr. Marc Goldfinger from Perspectum in Episode 2 of Life Sci AI: The Podcast series. During the episode, Marc expertly outlines the products he has been involved in and the steps Perspectum are taking to understand what happens to our internal organs post Covid-19. Dr. Marc Goldfinger is currently working as a product specialist focusing on product development and commercialisation for Perspectum’s new suite of medical devices. Marc has over 15 years’ experience in biomarker development in research and product development, with a keen focus on pathology, imaging and neurodegenerative disorders. More recently, Marc has focused on bridging different imaging modalities and biomarkers to improve disease assessment in hepatobiliary and gastrointestinal conditions. To speak to Nick, please drop an email to
February 05, 2021
Ep 1 | AI for Neuroimaging
In Episode 1 of Life Sci AI: The Podcast series, Dr. Olivier Joly the CSO of Brainomix joins Nick Mahoney to discuss the use of AI for neuroimaging. Dr. Joly is heading up an innovative team at Brainomix who have an AI-based e-stroke solution. Together they explore the advantages of the Brainomix product and where the application of AI for neuroimaging can end up in the future! Dr. Joly has dual training and holds a master's degree (M.S) in computer sciences from Bordeaux (ENSEIRB), France and a Ph.D. in neuroscience, neurophysiology and neuroimaging from the Katholieke Universiteit Leuven (KUL) medical school (Leuven, Belgium).  He has worked as an academic neuroscientist (in Belgium, France, and in the United Kingdom) for about 10 years. Since 2015, Dr. Joly has led the scientific research at Brainomix Ltd. His team is behind the algorithms of the AI-based e-Stroke solution that processes monthly more than 10k head scans of acute stroke patients worldwide. To speak to Nick, please drop an email to
January 25, 2021